News

Pirfenidone is an investigational therapy in the US and has not been approved by the US Food and Drug Administration (FDA). Expanded access programs provide a mechanism for

The distribution center represents a significant capacity upgrade in DKSH’s healthcare infrastructure in Malaysia. The new facility in Hicom Industrial Estate, Shah Alam replaces DKSH Malaysia’s older Central

The Bill & Melinda Gates Foundation joins existing investor, the Wellcome Trust, each investing $20m. The funds will enable Kymab to maximise the potential of its Kymouse platform

The new business will become Horizon CombinatoRx Incorporated, a wholly owned subsidiary of Horizon. Horizon CombinatoRx will provide access to the unique cHTS platform and Chalice analytics software,

Candesartan ASKA is an authorized generic (AG) of Blopress (candesartan cilexetil), which Takeda has licensed the patent to Aska. Aska had received approval for the drug from the

ELIGARD (leuprolide acetate for injectable suspension) is designed to reduce the amount of testosterone in the body by reducing its production. The company said that it is not

The supply and distribution agreement was first agreed to by the companies in November 2010 and is due to expire on 31 December 2014. As part of the

The company will provide its lead cell permeable peptide targeting inflammatory diseases to Dr. Robert Nussenblatt to investigate its efficacy in animal models of uveitis. Portage will also

Under the deal, Reckitt will be granted exclusive worldwide rights for the development and commercialization of XenoPort’s arbaclofen placarbil for all indications. Arbaclofen placarbil is a patent protected